drugset / Trial / NCT02053272
A Study of GWP42004 as Add on to Metformin in the Treatment of Participants With Type 2 Diabetes
RandomizedParallel-groupQuadruple-blindTreatment
Summary
A study to compare the change in glycaemic control in participants with Type 2 diabetes when treated with GWP42004 or placebo as add-on therapy to metformin over a period of 12 weeks. The safety and tolerability of GWP42004 compared with placebo will also be assessed.
Timeline
- Start
- 2014-02
- Primary completion
- 2016-02
- Completion
- 2016-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Tetrahydrocannabivarin | Small molecule | 2 mg | — |
| Comparator | Tetrahydrocannabivarin | Small molecule | 5 mg | — |
| Comparator | Tetrahydrocannabivarin | Small molecule | 15 mg | — |